Vitara Biomedical Stock

Vitara Biomedical developed a therapeutic platform to support premature infants.

Sign up today and learn more about Vitara Biomedical Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Vitara Biomedical Stock

Vitara Biomedical has developed a therapeutic platform to support premature infants. Vitara Biomedical's platform was inspired by natural physiological processes to transform neonatal care.

Funding History

August 2022$25.0M
September 2022$75.0M

Management

Chief Financial Officer

John B. Kelly

Founder, President & CEO

Jim McGlone

Press

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo